The International Paralympic Committee (IPC) has suspended the Iranian powerlifter Farzin Noori for four years for committing an anti-doping violation.
The athlete who competes in the up to 72kg class returned an adverse analytical finding for 19-Norandrosterone in a urine sample provided on 9 December 2017 following an out of competition test in Dubai, UAE, prior to competing at the 2017 Asian Youth Para Games. The test was conducted by the Asian Paralympic Committee as part of its testing programme for the event.
This substance is included on the World Anti-Doping Agency (WADA) 2017 Prohibited List under the category S1.1B Endogenous Anabolic Androgenic Steroids when administered exogenously.
As a result of his violation, Noori will be ineligible for competition for four years from 9 December 2017, the date of the test, to 8 December 2021. This means the athlete is not eligible to qualify or compete at the Tokyo 2020 Paralympic Games.
All his results obtained from 9 December 2017 and onwards will be disqualified including forfeiture of any medals, points, records and prizes.
The IPC would like to remind all athletes the principle of strict liability applies to anti-doping matters. Therefore, each athlete is strictly liable for the substances found in his or her sample, and that an anti-doping rule violation occurs whenever a prohibited substance (or its metabolites or markers) is found in his or her bodily specimen, whether or not the athlete intentionally or unintentionally used a prohibited substance or was negligent or otherwise at fault.
As a signatory of the World Anti-Doping Code (WADC), the IPC remains committed to a doping-free sporting environment at all levels. The IPC, together with the International Federations and the National Paralympic Committees, established the IPC Anti-Doping Code to prevent doping in sport for Paralympic athletes, in the spirit of fair play. The IPC Anti-Doping Code is in conformity with the general principles of the WADC.